Thank you for following Hormonal therapy (oncology). You will receive email notifications for this topic. To make changes to this, please visit your account.
You need to upgrade in order to follow more topics and receive email notifications about new articles and ratings, as your subscription allows only topic(s). To change which topics you follow, please visit your account.
![[Ad hoc announcement pursuant to Art. 53 LR] Roche’s giredestrant becomes the first oral SERD to show superior invasive disease-free survival in early breast cancer | Taiwan News | Nov. 18, 2025 14:00](https://www.biasly.com/wp-content/uploads/2020/02/news-thumb.jpg)
Taiwan News![[Ad hoc announcement pursuant to Art. 53 LR] Roche’s giredestrant becomes the first oral SERD to show superior invasive disease-free survival in early breast cancer](https://media.publit.io/file/c_fill,h_400,w_400/politicnation/fil-8QdV.jpg)
The Manila times
